EffectiveRXâ„¢ Panel Information
EffectiveRXâ„¢ Comprehensive Panel Intended Use
Intended as an aid to guide medication management decisions for patients who are prescribed to or under consideration for prescription medications associated with but not limited to cardiovascular health, psychiatry, pain management, addiction, or thrombophilia.
EffectiveRXâ„¢ Neuropsychiatric Panel Intended Use
Intended as an aid to guide medication management decisions for antidepressant, anti-anxiety and antipsychotic medications for individuals with behavioral disorders, major depressive disorder, or generalized anxiety disorder diagnoses.
EffectiveRXâ„¢ Panels Comparison
The chart below denotes which genes are included in the EffectiveRXâ„¢ Comprehensive Panel & the EffectiveRXâ„¢ Neuropsychiatric Panel.
| Gene | Comprehensive Panel | Neuropsychiatric Panel |
|---|---|---|
| ABCB1 | ✓ | |
| ABCG2 | ✓ | |
| ADRA2A(c.1252G>C) | ✓ | ✓ |
| ANKK1 | ✓ | ✓ |
| ApoE | ✓ | |
| COMT(Val158Met) | ✓ | ✓ |
| CYP1A2 | ✓ | ✓ |
| CYP2B6 | ✓ | ✓ |
| CYP2C19 | ✓ | ✓ |
| CYP2C8 | ✓ | |
| CYP2C9 | ✓ | ✓ |
| CYP2D6 | ✓ | ✓ |
| CYP3A4 | ✓ | ✓ |
| CYP3A5 | ✓ | ✓ |
| DBH(-1021C>T) | ✓ | |
| DPYD | ✓ | |
| F2 | ✓ | |
| F5 | ✓ | |
| GRIK4 | ✓ | ✓ |
| HLA-A*31:01 | ✓ | |
| HLA-B*1502 | ✓ | |
| HTR2A(rs6313) | ✓ | ✓ |
| HTR2A(rs7997012) | ✓ | ✓ |
| HTR2C | ✓ | ✓ |
| ITBG3 | ✓ | |
| IFNL3 | ✓ | |
| MTHFR (A1298C) | ✓ | ✓ |
| MTHFR (C667T) | ✓ | ✓ |
| OPRM1 (A118G) | ✓ | ✓ |
| OPRK1(rs1051660) | ✓ | |
| SLC6A4 | ✓ | ✓ |
| SLCO1B1 | ✓ | |
| UGT1A1 | ✓ | |
| UGT2B15 | ✓ | |
| VKORC1 | ✓ |